Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Archaeometric perspective on the emergence of brass north of the Alps around the turn of the Era. | Sci Rep | 2022 | 35013423 | PubTator, text mining | PubMed |
| Management of renin-angiotensin-aldosterone inhibitors and other antihypertensives and their clinical effects on pre-anesthesia blood pressure. | Anesth Pain Med (Seoul) | 2022 | 34991190 | PubTator, text mining | PubMed |
| Vasculopathy in COVID-19. | Blood | 2022 | 34986238 | PubTator, text mining | PubMed |
| Anesthetic management of cesarean section in a patient with Takayasu's arteritis: a case report. | JA Clin Rep | 2022 | 34985629 | PubTator, text mining | PubMed |
| Peptide fragments of bradykinin show unexpected biological activity not mediated by B1 or B2 receptors. | Br J Pharmacol | 2022 | 34978069 | PubTator, text mining | PubMed |
| Anti-MicroRNA-21 Oligonucleotide Loaded Spermine-Modified Acetalated Dextran Nanoparticles for B1 Receptor-Targeted Gene Therapy and Antiangiogenesis Therapy. | Adv Sci (Weinh) | 2022 | 34936240 | PubTator, text mining | PubMed |
| Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. | Pathobiology | 2022 | 34915500 | PubTator, text mining | PubMed |
| A rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19. | J Med Virol | 2022 | 34911144 | PubTator, text mining | PubMed |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. | Biomed Pharmacother | 2022 | 34801852 | PubTator, text mining | PubMed |
| Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis. | Cardiovasc Toxicol | 2022 | 34800264 | PubTator, text mining | PubMed |
| Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects. | J Trace Elem Med Biol | 2022 | 34798510 | PubTator, text mining | PubMed |
| SARS-CoV-2 involvement in central nervous system tissue damage. | Neural Regen Res | 2022 | 34782556 | PubTator, text mining | PubMed |
| Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. | Nat Rev Immunol | 2022 | 34759348 | PubTator, text mining | PubMed |
| A modular map of Bradykinin-mediated inflammatory signaling network. | J Cell Commun Signal | 2022 | 34714516 | PubTator, text mining | PubMed |
| β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgery. | Clin Transl Sci | 2022 | 34713976 | PubTator, text mining | PubMed |
| Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid. | Heart Fail Rev | 2022 | 34623544 | PubTator, text mining | PubMed |
| The cardiovascular effects of air pollution: Prevention and reversal by pharmacological agents. | Pharmacol Ther | 2022 | 34571110 | PubTator, text mining | PubMed |
| Ligand-directed bias of G protein signaling at the dopamine D2 receptor. | Cell Chem Biol | 2022 | 34302750 | PubTator, text mining | PubMed |
| Corrigendum to: Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy. | J Pharm Pharmacol | 2022 | 34190314 | PubTator, text mining | PubMed |
| Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease. | Cardiovasc Drugs Ther | 2022 | 34106365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=20